Abbott Laboratories (ABT) Revenue — Quarter Ended Mar 31, 2025
Revenue for the quarter was unchanged from the same quarter one year earlier. Compared with the immediately preceding quarter, revenue declined.
Key takeaway
Quarter ended Mar 31, 2025 · FY2025 Q1
Revenue for the quarter was unchanged from the same quarter one year earlier. Compared with the immediately preceding quarter, revenue declined.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$10.4B
Revenue reported for this quarter.
Quarter-over-quarter
-5.6%
Change from the immediately preceding quarter.
Year-over-year
+4.0%
Change from the comparable year-ago quarter.
Trailing four quarters
$42.3B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2024 | $10.4B | +4.0% |
| Sep 30, 2024 | $10.6B | +4.9% |
| Dec 31, 2024 | $11B | +7.2% |
| Mar 31, 2025 | $10.4B | +4.0% |
Revenue performance
The reported revenue was flat versus the prior-year quarter, following a pattern of year-over-year growth in the three preceding quarters. Sequentially, revenue decreased from the prior quarter.
Quarterly comparison
Compared with the immediately preceding quarter, revenue was lower. Relative to the same quarter one year earlier, revenue was unchanged.
What to watch
The sequential decline in revenue follows three consecutive quarters of year-over-year growth.